FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients - FDA Press Releases

FDA approves Gilenya (fingolimod) to treat multiple sclerosis MS in children age 10 and older. This is the first FDA approval of a drug to treat MS in pediatric patients

from Food and Drug Administration--Press Releases https://ift.tt/2jRSLuy
via IFTTT